ROCKAWAY, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) , (“electroCore” or the “Company”), a bioelectronic ...
electroCore, Inc. ( ECOR) announced that it has submitted a 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking clearance for its Quell wearable neuromodulation ...
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Hereditary transthyretin amyloidosis (ATTRv) is a fatal autosomal dominant disease characterized by systemic deposition of transthyretin amyloid fibrils. Authors present nineteen high-resolution ...
Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful CIPN (40.44% and 38.35%, respectively). HealthDay News — The pooled prevalence of chronic painful ...
Austin, United States, April 02, 2026 (GLOBE NEWSWIRE)-- As per SNS Insider, The Peripheral Neuropathy Market was estimated at USD 1.56 billion in 2025 and is expected to reach USD 2.66 billion in ...
More than 20 million Americans are affected by peripheral neuropathy – often struggling to find real, lasting relief. Many ...
A research team has successfully developed a next-generation coil interface capable of efficiently and safely stimulating peripheral nerves. This breakthrough is significant in that it greatly ...
Regular exercise is recommended for patients with chronic musculoskeletal pain. Because no specific type of exercise is superior, patients should be encouraged to engage in the type of low-impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results